Chromadex Corp Operating Margin vs. Current Valuation
| CDXC Stock | USD 7.72 0.08 1.05% |
Chromadex Corp Operating Profit Margin |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.35 | 0.6076 |
|
|
For Chromadex Corp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Chromadex Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Chromadex Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Chromadex Corp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Chromadex Corp over time as well as its relative position and ranking within its peers.
Chromadex |
Chromadex Corp's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.02 | Revenue Per Share 1.215 | Quarterly Revenue Growth 0.312 | Return On Assets 0.0051 | Return On Equity 0.0482 |
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Chromadex Corp Current Valuation vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Chromadex Corp's current stock value. Our valuation model uses many indicators to compare Chromadex Corp value to that of its competitors to determine the firm's financial worth. Chromadex Corp is number one stock in operating margin category among its peers. It is rated third in current valuation category among its peers reporting about 8,853,309,249 of Current Valuation per Operating Margin. At present, Chromadex Corp's Operating Profit Margin is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chromadex Corp's earnings, one of the primary drivers of an investment's value.Chromadex Current Valuation vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Chromadex Corp |
| = | 0.06 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Chromadex Corp |
| = | 554.22 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Chromadex Current Valuation vs Competition
Chromadex Corp is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 3.35 Billion. Chromadex Corp retains roughly 554.22 Million in current valuation claiming about 17% of equities under Health Care industry.
Chromadex Corp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Chromadex Corp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Chromadex Corp will eventually generate negative long term returns. The profitability progress is the general direction of Chromadex Corp's change in net profit over the period of time. It can combine multiple indicators of Chromadex Corp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4 K | -4.2 K | |
| Operating Income | -5.6 M | -5.9 M | |
| Income Before Tax | -4.9 M | -5.2 M | |
| Total Other Income Expense Net | 661 K | 694 K | |
| Net Loss | -4.9 M | -5.2 M | |
| Income Tax Expense | 1.5 M | 1.6 M | |
| Net Loss | -6.5 M | -6.8 M | |
| Non Operating Income Net Other | -58.5 K | -61.4 K | |
| Net Loss | -14.9 M | -15.6 M | |
| Interest Income | 661 K | 404.2 K | |
| Net Interest Income | 405 K | 425.2 K | |
| Change To Netincome | 6.8 M | 4.8 M | |
| Net Loss | (0.07) | (0.07) | |
| Income Quality | (1.44) | (1.37) | |
| Net Income Per E B T | 0.79 | 0.72 |
Chromadex Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Chromadex Corp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Chromadex Corp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Chromadex Corp's important profitability drivers and their relationship over time.
Use Chromadex Corp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chromadex Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chromadex Corp will appreciate offsetting losses from the drop in the long position's value.Chromadex Corp Pair Trading
Chromadex Corp Pair Trading Analysis
The ability to find closely correlated positions to Chromadex Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chromadex Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chromadex Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chromadex Corp to buy it.
The correlation of Chromadex Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chromadex Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chromadex Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chromadex Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Chromadex Corp position
In addition to having Chromadex Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
To fully project Chromadex Corp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Chromadex Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Chromadex Corp's income statement, its balance sheet, and the statement of cash flows.